rly-4008
relay therapeutics
['rly-4008']
 first data on rly-4008, a highly selective fgfr2 inhibitor in #cholangiocarcinoma 38 na ve and pretreated pts (with resistance mutations) stunning efficacy: with an orr 88% &amp; dcr 100% at the rp2d pfs &amp; os data urgently awaited #livertwitter 
Physician-scientist, focused on translational research in hepatobiliary cancer and precision medicine